Pfizer Animal Health is advising vets and horse owners to be on guard against the threat of West Nile Virus (WNV) in the UK, following a spate of outbreaks of the disease in several European countries this year.
West Nile Virus has recently made headline news because of a human outbreak in Greece which resulted in a number of deaths. Outbreaks have also occurred in Russia, Romania and Italy during 2010. West Nile Fever is a viral disease transmitted by mosquitoes, which carry the virus after biting infected birds. Primarily occurring between July and October, in line with typical peak activity of mosquitoes, it can have serious consequences on human and equine health, with severe cases resulting in fatal neurological disease.
There is no cure, though supportive treatment can aid recovery. However if the disease progresses to a state where the animal is not able to stand up, their chance of survival is considered low. Prevention of infection is difficult, but any steps that reduce mosquito numbers or the likelihood of horses and people being bitten may help to reduce the risk in areas where the disease is present. However, the only way to reduce the risk of an individual horse developing disease due to WNV is through vaccination.
Ben Gaskell, Pfizer's equine veterinary advisor said: "West Nile Virus may well become a very real threat to both horses and humans in Northern Europe. It is important for vets, horse owners and infectious disease experts to work together to mitigate its impact in the event of the virus becoming endemic across Europe. The rapid spread of the disease across North America is an illustration of what could potentially happen in Europe and it is important to remember there is no curative treatment - the only way to prevent clinical disease in horses is by vaccination."
Pfizer Animal Health supports the PrEquID (Prevention of Equine Infectious Disease) group, which consists of internationally recognised equine and infectious disease experts. The group was formed to develop guidelines on the prevention and control of a number of equine infectious diseases, on a global basis.
Klaus Osterrieder, Professor and Chair in the Institut für Virologie in the Veterinärfakultät at Freie Universität Berlin, Germany and a member of the PrEquID group advises: "Horse owners should ask their veterinarian for advice on appropriate prevention measures. Experience has shown that adopting a prudent prevention strategy can be a very effective way of managing this devastating disease."
Further information on WNV is available at www.westnile.eu.
A study published by Mike Dryden - one of the world's leading parasitologists - in Veterinary Parasitology has demonstrated that spinosad (Comfortis, Elanco) provides a high level of flea control one month after a single treatment and maintains a high level of effectiveness under conditions of natural challenge following subsequent monthly treatments.
The multi-clinic, investigator-blinded study1 was undertaken in client-owned dogs provided with three consecutive monthly treatments of oral spinosad (SPN) and fipronil/methoprene spot-on (FSM). All other household dogs and cats, to a maximum of four pets per household, were dispensed the same treatment. Subsequent treatments were given when the dog returned for whole-body flea counts and pruritus-scoring on days 30 and 60, with final assessments on day 90 (plus/minus five days on each occasion).
One hundred and twenty eight dogs were enrolled on the study at 10 veterinary practices in the USA (65 in the SPN arm and 63 in the FSM arm). On day 0, mean flea counts were 57.7 (range: 10-1469) and 44.8 (range: 10-717) for the SPN and FSM groups, respectively. On day 90, 55 of the 58 (95%) SPN dogs were flea free compared with only 21/55 or 38% of dogs in the FSM group. Mean pruritus scores declined to 0.92 (6.67 on day 0) in the SPN group and 3.83 (6.33 on day 0) in the FSM group by day 90. Mean flea counts were 0.08 and 5.19 for SPN and FSM groups respectively on day 90 correlating to a reduction in flea counts of 99.9% in the SPN dogs and 88.4% in the FSM dogs. Between treatment differences were found to be highly statistically significant (p<0.0001) for every parameter measured at every time point during the study in favour of SPN.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "The recent study confirms oral spinosad's outstanding efficacy in controlling fleas and associated pruritus in dogs when administered by owners following natural challenge in the home environment".
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.
References
1 Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs. Michael W. Dryden, William G. Ryan, Margie Bell, Anthony J. Rumschlag, Lisa M. Young, Daniel E. Snyder. Veterinary Parasitology 191 (2013) 340-346
CVS has announced that it is diversifying into pet grooming, opening grooming studios in its practices across the UK.
The company says the move is in response to the large number of clients that ask its staff to recommend a groomer in their area.
The new service has been branded MiGroomers and the first four studios have been opened at The Priory Veterinary Group and The Orchard Veterinary Centre in Nottingham, at Bridge House Vets in Mansfield, and at Haygate Veterinary Centre in Telford. Further studios are opening the Old Golf House Veterinary Group in Norfolk and in the Southwold-based Fromus Veterinary Group by the end of the month.
CVS says MiGroomers studios offer a full range of grooming services, all carried out by experienced groomers, Diploma-qualified to City and Guilds Level 2 or above.
Barry Brackner, Marketing and Commercial Director at CVS, said: "Given the frequency with which we are asked to recommend local groomers, moving into this growing sector where space in our practices allows it, seems a logical next step towards providing our clients with a one-stop-shop for all of their pet care requirements.
"It also enables us to offer additional career opportunities for our staff - something which is a priority for us at CVS. All of the current MiGroomers studios are being run by existing staff with an interest and qualification in grooming so it's a win/win and initial feedback from clients has been very positive. We will open further additional MiGroomers studios where we have the interest from staff and the potential to provide the appropriate facilities."
Of particular note is the guidance that prescriptions should no longer be written in mg/kg, as it may lead to errors when the dose is calculated.
The Standards and Advice update also answers questions about:
https://www.rcvs.org.uk/news-and-views/features/prescribing-pom-vs-joint-guidance-from-the-rcvs-and-vmd/
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
Vets4Pets has announced the opening of its 220th joint venture practice, together with a TV advertising campaign to support the growing business.
The 220th practice, opened with veterinary surgeon Lisa Bensley, is part of what the company describes as a 'healthy schedule of openings over the next few months', including two Companion Care practices in Pets at Home stores by mid June.
Lisa said: "I wanted to open my own practice so that I could to offer the standard of care I would want for my own pet. There are always so many frustrations when working for someone else in their practice.
"I really feel that Vets4Pets and Companion Care practices are the future, people are looking for a step up in veterinary care and services which I feel we can provide. It is so much more affordable than you would think and getting that business loan and the whole journey is made so easy. There is always someone on the end of the phone who will help with any problem and you are supported by so many people, experienced in their specific fields, covering any area you may need in your business ".
The television campaign (see below), which is running throughout June and July, focuses on 'Bug Packs' which are offered to all Vets4Pets clients and include 12 months vet recommended parasite treatments with 25% off.
Leigh-Anne Brown, Partner at Vets4Pets Harrogate and Chair of the Vets4Pets Professional Services Board said: "The reason we can manage to provide such a great deal is because of our size and an excellent commercial relationship with our suppliers which enables us to offer the discount. Now that Bug Pack has taken off we have the media buying power to advertise on national TV while our Online Marketing Team can even promote the package and sell the service online and the Local Marketing Team continue to implement the campaign on a more local level around each practice's community."
For more information about opening a Vets4Pets joint venture practice, call 0800 0280 513 or email partnership@vets4pets.com
Ceva Animal Health has launched Adaptil Stress Relief Now, a non-pheromone tablet to help dogs cope with predictable but unavoidable short-term stressful situations such as vet visits and car journeys.
The new product contains GABA, which, according to Ceva, plays a central role in relaxation by limiting the nerve cell activity in the areas of the brain associated with anxiety.1 It also contains L-tryptophan to increase serotonin synthesis1 and reduce stress-related behaviours in dogs.2 It also contains T-theanine, which Ceva says increases the release of GABA and inhibits the binding of the excitatory neurotransmitter L-glutamic acid to its receptors,1,3 with the effect of reducing anxiety and improving learning abilities.4 Finally, the product also contains B Vitamins (B1,B3, B6, B8 and B12), which the company says helps the body cope with the effects of stress.5
Ceva says that by administering the tablets to dogs two hours before any predictable stressful event and boosting levels of these naturally occurring substances, Adaptil Stress Relief Now tablets have been shown to help 80% of dogs remain relaxed in stressful situations, with the effect lasting up to four hours after administration.6
Sarah Endersby, Senior Veterinary Advisor at Ceva said: "Pet owners often want advice from their vets to help their dog's cope with a potentially stressful event that is approaching. Many want a reliable and quick-acting solution, especially if the event is infrequent or of a short duration. An oral anxiolytic can be really useful in this situation, and can be used alongside targeted behavioural training to help the dog cope."
According to the company, study trials have proven a high safety margin, with no recognised side effects and no impact on clinical parameters.6 In palatability trials, 90% of dogs chose to eat them with no prompting.6
Ceva recommends the new product is used alone or in combination with other products in the existing Adaptil range for common stressful situations for dogs, including: house parties / visitors, fireworks, thunderstorms, noise phobias, travel, veterinary visits and visits to groomers.
For more information about Adaptil Stress Relief Now tablets, including client literature, please speak to your local Ceva representative.
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo
The teleconsulting service, accessed via the VetCT App, offers general practitioners 24hr clinical advice and support from specialists in all disciplines.
Practices who subscribe to the service can apply for £15 per person of food and drink vouchers for up to 20 people, to enjoy together.
VetCT says it will also be hosting a virtual party for locum vet subscribers want to take them up on the offer.
Victoria Johnson, Founder and Co-Director said: “We wanted to encourage people to get together - in person or virtually - to enjoy some festive treats and all-important social time, especially after a challenging year.
"We also appreciate how reducing staffing over the seasonal holiday period can leave teams stretched, and want to reassure our clients that we’re here to support them, 24/7, throughout the festive season.”
A member from the VetCT team will join the start of each practice party, to explain how versatile the teleconsulting service can be in providing reassurance and support, with answers to quick clinical questions, as well as advising on complex, multi-disciplinary case queries.
For more information, contact: info@vet-ct.com using the words ‘Staff Party’ in the subject, or visit www.vet-ct.com for more information.
Dairy vets will soon be receiving a DVD highlighting the economic losses due to coccidiosis in cattle, from Janssen Animal Health.
According to the company, coccidiosis is a major cause of scouring and poor growth rates in calves yet recent findings have demonstrated that a massive 61 per cent of the economic loss occurs in sub-clinically infected calves that are not showing any obvious clinical signs. Treated calves have been shown to put on 20 per cent more weight than untreated calves1. Coccidiosis infects between 16 and 27 per cent of adult cattle who act as reservoirs of the disease2,3,4,5. This means that most calves are likely to become exposed to the infectious form of the parasite. After the age of 6 months the majority of calves acquire immunity but if they are exposed to a massive challenge before that time due to large numbers of the coccidial oocysts or due to a stress factor, sub-clinical or clinical disease occurs.
The DVD describes the challenges involved in diagnosing coccidiosis and how to interpret faecal oocyst counts, as well as some of the characteristics of sub-clinical infection in calves. The benefits of metaphylactic and preventative approaches to treatment with Vecoxan®, the only anticoccidial drench licensed for beef and dairy cattle at any age, indoors and out, are discussed.
Nigel Underwood from Janssen Animal Health said: "The diagnosis of non-specific scour is problematic at best but it is important that vets have coccidiosis at front of mind when considering the differential diagnosis. Prompt treatment of the whole batch of calves can stop the disease in its tracks and does not interfere with the development of future immunity. We hope this DVD will provide an update on the latest thinking and help increase recognition of this disease."
The DVD will be sent out in February and any vet with an interest in the disease who does not received one before the end of the month should call Janssen on 01494 567555 to request a copy.
Further information is available from Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG Tel 01494 567555 Fax 01494 567556 Email: ahealth@jacgb.jnj.com
The Pet Doctors Group has announced that it will continue its New Graduate Programme for Autumn 2010, an initiative which the company says has proved successful since its launch in 2008. The aim of the scheme is to appoint new graduates to work in a selected number of its practices, spread across the South East of England.
Brodie Collins, Area Manager at Pet Doctors, will be meeting final year students at the Bristol University School of Veterinary Science, the Royal Veterinary College in London and the University of Cambridge Veterinary School during February and March 2010 to promote the scheme and explain the firm's approach to supporting graduates during their critical first year in practice. Successful applicants will be shortlisted by August 2010 with appointments made by September.
With the economic climate causing many practices to postpone recruitment or reduce support and training for new qualified graduates, competition for places on schemes such as this is expected to be high this year.
Brodie said: "The first twelve months out of vet school can be the most daunting of a vet's career. They're suddenly thrust into a public facing role with little experience of communicating with clients or making a diagnosis. Many have limited surgical experience and even fewer have business acumen. They really need structured support and training to build their confidence and enable them to perform effectively both from a clinical and a business perspective. Mentoring is a key support tool so our graduates are all placed with practices where this can be provided regularly.
Feedback from our scheme last year showed that what the graduates we recruited most valued was working within a team which encouraged them to be open and honest so that they could readily ask for advice and help when they needed it. We're all individuals and perform much better if we feel comfortable with the people we're working with. Our scheme enables us to build on our graduates' strengths and support them in areas which they find more challenging.
We provide clinical and surgical training but also focus on the development of communication and management skills to help graduates fulfil their role as part of a business team. The graduates we appoint will each spend their first year based within one of our smaller practices, working as part of a small and closely knit team. At the end of the first year, if all is going well, they will have the option to stay on and help grow that practice.
In addition to veterinary skills, we're looking for graduates with a good personality fit, a strong work ethic, a caring approach and ideally some level of business understanding."
For further information on the scheme, please contact Brodie at Brodie@petdoctors.co.uk
The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals which afford the UK additional protection against rabies, ticks and tapeworms.
The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision.
The transitional arrangements allow the UK to impose stricter measures on the entry of pet animals and are designed to protect the UK from rabies, ticks and tapeworms (Echinococcus multilocularis).
The vote in the European Parliament today supports an extension of these arrangements until the end of 2011 and puts in place a system so that permanent measures can be imposed in the future for entry to specific Member States based on scientific evidence. The decision will have to be ratified by the European Agriculture Council before coming into force.
Parasitologist Maggie Fisher from ESCCAP said: "This provides the UK with invaluable time to mount a solid scientific case for retaining the requirement for tick and tapeworm treatment indefinitely."
Professor Bill Reilly, President of the BVA, said: "The BVA and BSAVA have worked closely with Defra to secure this extension to the arrangements and we will now be pushing for investment in additional scientific research that will give us a clearer picture of the threat of the parasite Echinococcus multilocularis and other exotic and emerging diseases."
Dr Richard Dixon, President of BSAVA, added: "This decision in Europe is strongly welcomed and we are pleased that veterinary associations across Europe supported our position. The next stage is to gather further evidence to ensure the UK is protected in the future.
"In the meantime, the key message for pet owners is that they must talk to their vets as early as possible to find out how to protect them from disease and parasites when travelling abroad."
The RCVS President and Principal of the RVC, Professor Stuart Reid, has announced that he is to run the London Marathon on 26 April, in aid of the RVC Animal Care Trust, the Veterinary Benevolent Fund (VBF) and Mind.
The RVC Animal Care Trust will use the funds to assist the student bodies at all of the UK veterinary schools. The VBF, through Vetlife, the Vet Helpline and the Veterinary Surgeons' Health Support Programme, offers specific assistance to members of the veterinary team. Mind has been working with the profession and the veterinary schools at all levels in developing approaches to mental health and wellbeing.
Stuart said: "As President of the RCVS and Principal of the RVC I feel that I am in a privileged position and I would like to take every opportunity to help break down the stigma associated with mental health and wellbeing, and to raise what I can to assist these three excellent charities in dealing with what is, sadly, a major issue for us.
"Most of all, I am doing it for the nine people I know personally who are no longer with us, and the many more who have found, and will find, help in time."
If you'd like to help Stuart meet his sponsorship target of £10,000, you can sponsor him at: uk.virginmoneygiving.com/StuartReid.
Alfaxan®, Vetoquinol's injectable general anaesthetic, is one year old this month. To celebrate the occasion, and the product's use by 860 UK practices in over 80,000 procedures so far, Vetoquinol is offering a free Alfaxan party bag.
The party bag includes an Alfaxan anaesthesia monitoring chart and an Alfaxan vet brochure with dosage chart and timer. In addition, everyone who claims a party bag will be entered into a lucky dip. Ten winners will be chosen at random to receive an oesophageal stethoscope kit, containing one normal stethoscope, with a removable head, and three Portex oesophageal stethoscope probes (small, medium and large) for monitoring patient’s heart and respiratory rate.
To claim your party bag, call the dedicated Alfaxan technical support line on 0800 345 7560 or email: MyAlfaxanPartyBag@vetoquinol.co.uk.
Vetoquinol also reports a very positive response to Alfaxan from the profession during its first year. Simon Boulton, one of Vetoquinol’s Veterinary Advisors, has been conducting wet labs across the country for the company. He said: "Vets have used the wet lab service to get me along to anaesthetize patients for the day using Alfaxan. I have had a great deal of positive feedback and the product is becoming more and more widely used. Extremely smooth and reliable inductions, followed by good cardiovascular and respiratory stability were the most noticeable features of Alfaxan anaesthesia, liked by both the vets anaesthetizing the patients and the nurses who monitor them."
The Disciplinary Committee of the Royal College of Veterinary Surgeons last week ordered a month's suspension for a veterinary surgeon from Dolgellau for dishonest certification of bovine tuberculin testing in the Gwynedd area in early 2007.
At a hearing that concluded last Friday, Iwan Parry, a partner of The Veterinary Surgery, Bala Road, Dolgellau, and an Official Veterinarian, was charged with serious professional misconduct for certifying on eight separate occasions that he had tested and inspected cattle for clinical signs of bovine tuberculosis (TB), when he had not done so. At the outset of the hearing, Mr Parry denied the charges.
The Committee heard that Animal Health (a DEFRA Executive Agency) had discovered irregularities in TB testing paperwork from Mr Parry's practice. These included two locum veterinary surgeons, who were not Local Veterinary Inspectors (LVIs), having carried out TB pre-movement testing, but the relevant paperwork being signed and certified by Mr Parry. It therefore suspended him from LVI duties and lodged a complaint with the RCVS.
The Committee heard that, at the time, Mr Parry's practice was in difficulty as all eight of his assistant veterinary surgeons had recently left and he was struggling to maintain services. It was also reported that the incidence of bovine TB in Mr Parry's area was very low.
Under questioning, Mr Parry admitted that he had not done the testing, but had allowed non-LVI veterinary surgeons to do so and then signed the certificates himself. Denying the charge of dishonesty, he maintained that he had thought his actions were legitimate, providing he questioned the veterinary surgeons afterwards and checked their results. However, he told the Committee he now deeply regretted this "honest mistake", made at a time of great personal pressure, and that it would not be repeated.
The Committee also heard evidence from a number of character witnesses, including Mr Elfyn Llwyd MP, testifying to Mr Parry's good character, integrity and good standing in the local community and agricultural sector.
Nevertheless, in view of Mr Parry's long experience as an LVI, his understanding of the importance of routine herd testing and accurate veterinary certification and his reputation for keeping up to date with legislative and professional developments, the Committee decided that his actions were not just inappropriate, but were the result of conscious impropriety on his part. It found that he was not only guilty of dishonesty, but of allowing non-LVIs to perform TB testing, both of which amounted to serious professional misconduct.
In passing judgment, the Committee emphasised that the integrity of veterinary certification was of the utmost importance, especially when carried out on behalf of the Government, in order to safeguard animal health and facilitate international trade. It also felt that Mr Parry could not have failed to have been fully aware of what he was signing and that he should not have done so.
It was, however, prepared to take account of some exceptional mitigating factors in this case, including the low risk of TB spread following Mr Parry's actions; that no financial gain had been sought or received by him; his unblemished career and uprightness of conduct to date; the esteem in which he was held in the farming community and the potential (financial) impact on that community if he were to be removed from the Register (therefore unable to practise) for a significant period of time.
Nigel Swayne MRCVS, chairing the Disciplinary Committee, concluded: "We are reminded that the primary purpose of any sanction is not punishment, but the maintenance of public confidence in the profession and to uphold professional standards of conduct.
"Whilst only a reprimand is not an appropriate sanction where dishonesty and false certification have been found proved, and such findings would normally attract at least a long period of suspension, given the wholly exceptional circumstances of this case and the strength of the mitigating factors, we direct that Mr Parry should be suspended for one month."
Dechra Veterinary Products has picked up a major award at the 2011 Veterinary Marketing Awards for a calendar called 'The Horse in History'.
The calendar, designed to promote all of Dechra's equine products but particularly Equipalazone, also won the award for most innovative use of direct mail. The company's website, http://www.dechra.co.uk/, was highly commended in the New Media category.
The John O'Hara Award is made to the VMA category finalist which, in the opinion of the judges, best demonstrates a high level of innovation or adventurousness in an aspect of the advertising mix. Designed to celebrate the unique position of the horse down the ages in culture, art, science and legend, the calendar featured twelve iconic illustrations, from the white horse carved into the chalk hillside in Uffington, Oxfordshire, to Da Vinci's sculpture.
It also included an embedded competition giving practices the opportunity to win practical aids, including wind up torches and water bottles, with the major prize being a trip to Vienna to see the Lipizzaner Stallions at the Spanish Riding School.
Larry King, Senior Brand Manager at Dechra, said: "Horses have had a unique relationship with man for thousands of years and this is what we wanted to celebrate with our calendar. The monthly competition with 100 prizes on offer and the special prize draw at the end of the year gave it a real point of difference and it proved very popular with our customers. It was the first time we'd run such a campaign over twelve months and we believe it to be unique in the animal health sector.
"We were delighted and honoured to win both the award for best use of direct mail and the John O'Hara award for The Horse in History. It will inspire us on our quest to continually set new standards in the way we communicate with our customers."
The Norman Cavalry
Galloping Horse
The Uffington White Horse
The Anatomy of The Horse
Incitatus
Bucephalus
Altamira Cave Painting
Gran Cavallo
Rocinante
American Carousel Horse
Aethenoth
Researchers at the Animal Health Trust are appealing for information from veterinary surgeons who have seen recent Eosinophilic Keratitis (EK) conditions, an emerging issue in UK equine ophthalmology.
The AHT says that despite the increased awareness of EK worldwide, the aetiopathogenesis of the disease remains poorly understood and probably underdiagnosed. The charity is looking to define the pathogenesis and determine why some horses are particularly susceptible to this condition, in particular looking for epidemiological links, environmental factors and parasitic infestation.
Many of the clinical signs of EK are non-specific and similar to other corneal conditions such as blepharospasm, chemosis, conjunctival hyperaemia, epiphora or perilesional oedema. More specific signs include caseous mucoid discharge and white/yellow plaques often localised in the peripheral cornea. The degree of pain varies and concurrent ulceration is almost always present. Conjunctivitis may also occur in association with the keratitis or as a unique disease entity.
EK can have variable clinical presentations, from a thick caseous accumulation to a more superficial plaque of “ground-glass” appearance. They may present as chronic non-healing ulcers that respond quickly to the use of topical steroids and/or ciclosporin, or present with marked ocular discomfort and require superficial keratectomy to resolve the condition.
Two different corneal locations are classically (though not exclusively) involved in EK, the medial perilimbal cornea, often under the third eyelid, or the lateral perilimbal cornea, which may progress axially towards the central cornea.
The charity is also providing free cytology tests for corneal scrapes to help vets diagnose EK earlier, thereby avoiding secondary complications that can lead to permanent visionary impairment.
If you have seen cases that have either been diagnosed as or that you suspect to be Eosinophilic Keratitis this year, contact Sonia Gonzalez-Medina on 01638 751000 Ext: 1203 or sonia.gonzalez-medina@aht.org.uk.
For more information and to download a copy of the submission form to accompany samples, visit www.aht.org.uk/EKstudy.
The webinar, ‘Dealing with Difficult Situations’ will take place on Tuesday 7th December at 7.15pm and will feature veterinary surgeons who themselves recently joined the Register giving examples of challenging situations they faced, how they dealt with them, what they learned and how it changed the way they practise.
Gemma Kingswell, RCVS Head of Legal Services (Standards), said: "We recognise that starting in your first job as a veterinary surgeon is very exciting, but that the first few months in practice can be daunting too as you encounter challenging situations for the first time.
“This webinar aims not only to provide some practical guidance on how to deal with difficult situations in a pragmatic way should they arise, but also provide some reassurance that you are not alone in facing them.
"The webinar will also explore how the speakers have reflected on the difficult circumstances they have encountered in order to build up the knowledge, confidence and resilience to deal with similar situations in the future.”
Among those sharing the situations they’ve encountered are: Izzy Hocking, Hannah Prestwood and Bolu Eso.
They will be covering topics including the provision of pragmatic care, how to have difficult conversations with clients and how to handle client confidentiality.
Gemma will then explore the scenarios further in relation to the Code of Professional Conduct and what it says about how best to handle such difficult situations.
To sign up to the webinar visit: www.rcvs.org.uk/news-and-views/events/difficult-situations.
Those who are interested in attending can also submit questions about the Code and supporting guidance in advance via the Eventbrite registration page.
There will also be opportunities to ask questions throughout the event.
For those who aren’t able to make it on the day, a recording of the webinar will be made available shortly afterwards via the RCVS website.
Defra has today published reports from the Health and SafetyExecutive and Professor Brian Spratt, of Imperial College London,into the recent outbreak of Foot and Mouth Disease in Surrey. The report is available here.
Oxyglobin, Dechra’s unique haemoglobin-based oxygen carrying fluid for the treatment of anaemia in dogs, is now readily available in the UK.
“Over the past year, demand for this leading product has outstripped our limited supply from the manufacturer Biopure®,” explains Carol Morgan, product manager at Dechra Veterinary Products. “Production and supply issues in the US have now been resolved which means we can assure the future supply of Oxyglobin via the wholesaler to practices.”
Dechra is the sole distributor of Oxyglobin in the UK. The product requires no typing or cross matching and ensures no transfusion reactions or disease transmissions. “Its effectiveness can be measured by a rapid improvement in clinical signs, increased plasma haemoglobin concentration and arterial oxygen content. Oxyglobin has certainly proved itself as a valuable product to have in any practice,” adds Carol Morgan.
Oxyglobin can be stored at room temperature and has a shelf life of three years. For further details, please contact your local territory manager or phone Dechra on 01743 441 632.
Genitrix has taken on the exclusive UK distribution of the Oxbow Professional range of premium recovery diets for herbivores and carnivores.
The Oxbow range was developed in the USA, covers a wide range of exotic species, and is offered in multiple pack sizes to ensure ease of use and cost effectiveness. Key products within the range include Critical Care, Critical Care Fine Grind and new Carnivore Care.
Carnivore Care is a recovery diet for carnivores including cats, ferrets, raptors and snakes, which are unwilling or unable to eat their normal diet. Developed specifically for carnivorous mammals, reptiles and birds, it contains easily digestible proteins, as well as high taurine and L-carnitine in a powdered formula which is easy to mix. It can be self fed, fed by syringe or even by tube to cats, ferrets, raptors, and other carnivorous small mammals and reptiles. It is used for conditions including malnutrition, severe weight loss, appetite stimulation, gastroenteritis, pre and post surgical care and as a medication carrier.
Critical Care is a recovery diet for herbivores, including rabbits, guinea pigs, hamsters, tortoises and other herbivorous mammals and reptiles. Formulated to contain all essential nutrients, as well as timothy hay to ensure proper gut physiology and digestion, it can be self fed or fed by syringe and is used in cases including gastrointestinal stasis, severe weight loss, dental disease/post extraction, for gastric hair balls and pre and post surgery
Critical Care Fine Grind is a recovery food which is particularly suitable in cases where tube feeding is required. Formulated to contain timothy hay and essential nutrients, it is offered in a fine particle size to ensure easy flow through nasogastric tubes and syringes. It can be used to feed herbivorous mammals and reptiles unwilling or unable to eat due to illness, surgery or poor nutritional status.
John Chitty BVetMed, CertZooMed, CBiol, MIBiol, MRCVS of the JC Exotic Pet Consultancy said: "In my opinion, the Oxbow Professional Line is the best recovery diet range on the market as it gives vets a variety of high quality options for multiple species. It can make really make the difference in a successful recovery."
Howard Wilder, Genitrix' Managing Director, said: "We're focused on delivering innovative products for companion animals and exotic pets which advance veterinary care and provide revenue opportunities for veterinary practices.
"The Oxbow range covers a uniquely wide range of species giving vets a flexible 'one range fits all' recovery care diet for convalescing pets, which has been well researched and formulated. We're delighted to launch the Oxbow Professional range in the UK and believe many veterinary practices will find it a beneficial addition to their armoury."
Ceva Animal Health has produced a leaflet to help horse owners understand the cause, diagnosis and management of equine back pain.
The company says the management of back pain in the horse can be a particular challenge to vets and a source of frustration for owners. Early diagnosis is likely to be associated with a more favourable outcome but it's important to ensure that other causes of pain and poor performance such as lameness, are not contributing to the horse's clinical signs.
'Understanding back pain' explains the anatomy of the back, as well as the clinical signs of back pain, and how it is diagnosed, including the treatment options and the general prognosis. Copies of the new leaflet are available, free of charge, from your Ceva sales representative. Leaflets on 'Understanding bone spavin', 'Understanding navicular disease', 'Understanding sacroiliac disease' and 'Equidronate discharge instructions', are also available.
For further information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Dr David Reese, Director of VetCT Australia and a Diplomate in veterinary diagnostic imaging will present: "Leveraging CT to Diagnose and Manage Unusual Pets", followed by a Q&A session.
David said: “This webinar is a fantastic opportunity to share knowledge about optimising imaging for exotic animals to reach an accurate diagnosis.
"The field of exotics imaging has rapidly advanced in recent years.
"With the increasing use of CT alongside traditional radiography, we can see so much more and provide high-quality reports to our client practices that empower them to give great care.
"We’re excited to support Exotic Vet Support with this CPD programme.”
Attendees will also receive an exclusive discount for the Exotic Vet Support Asia-Pacific (EVSAP) Conference 1st-2nd March 2024 in Sydney.
A recording of the webinar will be available after the live session, and for attendees of the EVSAP Conference.
Register here: https://vetct.zoom.us/webinar/register/WN_i_8KgMbPSeGZ-i7AbxaDqw#/registration
"Reasons to be fearful? Rising proportions of positive faecal worm egg counts among UK horses (2007–2023)1" which was conducted in collaboration with Animal Health Vision International, the University of Liverpool and jDATA Pty (Ltd), analysed quarterly surveillance data summaries of FWEC test results that were submitted to the Equine Quarterly Disease Surveillance report (EQDSR) by 36 UK laboratories.
Of these, 18 laboratories provided additional details through a survey on the testing methods adopted.
The researchers say there was considerable variation between laboratories in both the FWEC test methods used and the FWEC positivity thresholds applied to designate a test result as positive for either surveillance reporting or for treatment purposes.
However, the analysis revealed an increase in the proportion of positive FWECs over time, even after accounting for the time of year that testing was conducted, the FWEC positivity threshold used for reporting a sample as positive and the laboratory undertaking the testing.
Researchers say these findings raise questions about targeted treatment strategies, where anthelmintics are administered if FWECs exceed a certain threshold.
If this threshold remains low, the increasing proportion of positive FWECs that were identified would lead to increased use of wormers, potentially accelerating the development of anthelmintic resistance.
This highlights the need to better understand the factors driving rising FWEC positivity rates and if they are a cause for concern.
For example, is this trend leading to increased numbers of horses exceeding the treatment threshold and therefore being recommended for treatment?
The study authors say that the continuation of coordinated efforts to enhance parasite control strategies across the UK equine industry is essential.
The recently available guidelines from the British Equine Veterinary Association (BEVA) and CANTER provide essential resources for vets, pharmacists and RAMAs/SQPs who prescribe equine anthelmintics to optimise parasite control2,3.
Merial has launched a new website where you can test your NSAID knowledge and get the chance to win a £50 book voucher. There’s a new winner every month.
The website, http://www.osteoarthritisindogs.co.uk is designed to help practice staff understand more about canine osteoarthritis (OA) and effective management of the condition. The site covers every aspect of canine OA, including treatments and non-pharmacological management strategies. There is also a section for dog owners where practice staff can direct their customers for further information.
Merial product manager Claire Parry-Baggott said: “The practice section is password protected but registration is quite straightforward. The test itself consists of 10 multi-choice questions and your test results are returned within a matter of a few seconds.”
Claire added: "Canine osteoarthritis is a challenging area on its own but is further complicated by the choice of NSAIDs that serve the market. All NSAIDs inhibit the COX-2 enzyme which plays the key role in the development of pain and inflammation. However, traditional NSAIDs also inhibit COX-1 to widely varying degrees. This is a beneficial enzyme that plays an important role in normal physiological functioning. The resulting unwanted side-effects of COX-1 inhibition may hinder therapy, however this is not yet recognised by many vet practices.
“This site will help vets and practice staff better understand canine OA, whilst giving a clearer picture of how different NSAID’s interact with COX-1 and COX-2. The new generation NSAID – firocoxib (Previcox®), selects COX-2 whilst sparing COX-1 and so is a real step forward in the treatment of canine OA.”